Presto! Proposal eliminates stolen-drug danger

"Drug companies are apparently reluctant to pay the nominal cost of tagging pills and bottles (only about 25 cents a bottle, after an initial investment of $1 million to $2 million)" to implement track-and trace technology, according to a poorly informed New York Times op ed piece. Authors Katherine Eban and J. Aaron Graham, severely misinformed about not just product and implementation costs but also technical challenges, say that the $75 million in drugs taken from an Eli Lilly warehouse last month were not so tagged, making it all the more difficult to find them if they re-enter the legitimate drug supply chain. "The FDA should require that drug makers tag every bottle," they say. "With track-and-trace technology, it is easy to find the packages that are safely in the possession of legitimate wholesalers, hospitals and drugstores." Article

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.